(HYPR) Hyperfine, Inc. Business Model Canvas Research

Regional sales distributors help Hyperfine, Inc. reach markets beyond its U.S. direct sales team, which matters most for international rollout and local rules. They also cut friction in installation and service logistics, so each new market can be supported without building a full local team from scratch.

• Expand access beyond U.S. teams
• Support local market entry
• Coordinate installs and service

Clinical and regulatory advisors help Hyperfine, Inc. turn portable MRI hardware into a reimbursable product by guiding FDA pathways, evidence plans, and clinician adoption. In a market where one failed study or labeling issue can delay launch by months, their input cuts execution risk and helps clear adoption barriers.

• Guide FDA 510(k) strategy
• Shape evidence-generation plans
• Support reimbursement access
• Reduce launch and adoption risk

Hyperfine, Inc. depends on FDA clearances and recurring compliance work to keep its Swoop system in market and support new product claims. That means repeat 510(k) submissions, technical files, and post-market controls, because one missed control can slow access and delay expansion.

• FDA clearance is a core gate.
• Submissions and docs repeat often.
• Post-market controls protect access.

Hyperfine must sell, install, train, and support Swoop at customer sites, because the scanner is used inside live clinical workflows. Field service is core to adoption: quick setup, user training, and fast issue resolution shape renewals, referrals, and day-to-day customer trust.

• On-site install and workflow training
• Fast field support for clinical use
• Service quality drives renewals and referrals

Hyperfine, Inc. depends on engineers, scientists, clinical specialists, and service teams to build and deploy its portable MRI systems. In a high-precision medtech business, that talent is the key resource that supports product refinement, regulatory execution, and customer installs.

• Engineering drives product innovation
• Clinical teams support hospital use
• Service staff speed deployment
• Skilled labor lowers field risk

Hyperfine, Inc.'s brand and installed base support trust in point-of-care MRI, with revenue of $5.7 million in Q1 2025 and a net loss of $8.1 million, showing the business still depends on adoption momentum. Each installed system can drive referrals, service revenue, and faster learning, which helps the Hyperfine name look more proven in clinical settings.

• Installed systems build market credibility
• Existing sites can generate service revenue
• More placements support referral growth
• Adoption proof matters in point-of-care imaging

Hyperfine's value is the Swoop MRI system plus software and services in one stack, so hospitals deploy one vendor instead of stitching together hardware, apps, and support. In FY2025, that kind of integration helps improve adoption, training, and workflow consistency across care sites.

• One system, fewer handoffs
• Faster setup and use
• Better end-to-end customer experience

Hyperfine, Inc.'s 64 mT portable MRI can reach smaller hospitals and nontraditional care sites that may not support a fixed scanner, so access is no longer tied to large tertiary hospitals. That makes imaging easier to place in emergency, inpatient, and rural settings, where speed and site fit matter most.

• 64 mT portable MRI
• Fits smaller care sites
• Expands imaging access

Large health systems need ongoing account management after deployment, because one MRI install can lead to more site placements, renewals, and training needs. Hyperfine, Inc.'s account teams help protect retention and grow revenue by coordinating expansion across departments and locations.

• Manage post-sale hospital relationships
• Drive renewals and expansion
• Support multi-site placements

Hyperfine’s clinical partnership model depends on early adopters and opinion leaders who help validate the 0.064T Swoop MRI in real care settings. That matters because Hyperfine’s FY2024 net revenue was still only in the low tens of millions of dollars, so each strong site can add feedback, publish cases, and drive referrals through shared outcome gains, not just sales.

• Early sites shape product use
• Case studies build clinical trust
• Referrals come from outcomes

Service and installation teams are a core channel for Hyperfine, Inc. because Swoop systems must be placed and used in clinical sites. They bridge the sale and daily use by installing, training, and supporting staff, so this channel directly shapes post-sale uptime and the customer experience.

• Install in clinical environments
• Train users on-site
• Support post-sale adoption

Hyperfine, Inc. uses digital marketing, conference booths, and medical meetings to turn awareness into qualified leads, which matters in a niche market where buyers often need education before purchase. These channels also help explain the portable MRI use case and keep the sales pipeline active while the Company expands physician and hospital reach.

• Builds awareness in a narrow market
• Educates clinicians and buyers
• Supports lead generation and pipeline

Stroke and neurology centers are a core fit because acute stroke care depends on fast brain imaging for triage, monitoring, and treatment choice. Hyperfine’s low-field MRI supports bedside neurological pathways, and this group matters for its clinical value story because stroke is a leading cause of disability, with about 795,000 strokes a year in the U.S. alone.

• Fast imaging supports time-critical triage
• Low-field MRI fits neurology workflows
• High relevance to clinical adoption

Academic medical centers are Hyperfine, Inc.'s key early adopters because they test new imaging tools, compare workflows, and generate the peer-reviewed evidence that drives wider trust. Their publications and teaching role can speed adoption across community hospitals, so one strong academic site can influence many buying decisions.

• Early adopters and trial partners
• Build clinical evidence and trust
• Shape broader physician adoption

Regulatory and clinical costs are a core fixed burden for Hyperfine, Inc.: FDA compliance, design documentation, and clinical studies must run continuously for medical imaging products, and they also prove safety and performance. These costs can stay elevated for years, so they hit cash flow before scale benefits show up.

• FDA compliance is mandatory.
• Clinical studies stay ongoing.
• Documentation adds recurring spend.

Hyperfine, Inc. must fund finance, legal, HR, IT, and corporate governance, and public-company reporting adds extra cost for SEC filings, audit work, and board oversight. These general and administrative costs support the business, but they do not directly build or ship MRI devices, so they can pressure margins when revenue is still small.

• Finance, legal, HR, IT
• SEC and audit overhead
• Supports operations, not device output

International sales can grow Hyperfine, Inc.'s revenue through regional distributors or direct entry, widening demand beyond the U.S. Local channel setup still affects pricing and margins, because distributor spreads and import costs can take a meaningful cut. This stream matters most where hospitals want portable MRI but U.S. adoption is slower.

• Wider addressable market
• Distributor margins can compress pricing
• Direct entry can lift control

Financing and placement arrangements help Hyperfine, Inc. sell Swoop systems to buyers that want lower upfront cash use. Lease-like terms can spread a six-figure capital purchase over time, which fits hospitals and clinics with tight budgets and can widen placement in underfunded settings.

- Lowers upfront adoption cost
- Supports budget-limited buyers
- Can speed system placement